N(1)Gly-DL-Asn-DL-Trp-DL-His-Gly-DL-xiThr-DL-Ser-DL-Pro-DL-Asp(1)-DL-Trp-DL-Phe-DL-Phe-DL-Asn-DL-Tyr-DL-Tyr-DL-Trp(7-OH)-OH
| Internal ID | fb338386-d12d-48f4-b7c0-eb7edc797650 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[2-[[2-[[4-amino-2-[[2-[[2-[[2-[[18-(2-amino-2-oxoethyl)-6-(1-hydroxyethyl)-3-(hydroxymethyl)-12-(1H-imidazol-4-ylmethyl)-15-(1H-indol-3-ylmethyl)-2,5,8,11,14,17,20,23,27-nonaoxo-1,4,7,10,13,16,19,22,26-nonazabicyclo[26.3.0]hentriacontane-25-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(7-hydroxy-1H-indol-3-yl)propanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C103H115N23O25/c1-53(128)88-101(148)124-80(51-127)102(149)126-33-13-23-81(126)100(147)122-78(44-85(134)109-49-86(135)113-76(42-83(104)132)97(144)118-74(39-59-46-108-68-22-11-9-19-65(59)68)96(143)120-75(41-61-48-106-52-112-61)90(137)111-50-87(136)125-88)99(146)119-73(38-58-45-107-67-21-10-8-18-64(58)67)95(142)116-69(34-54-14-4-2-5-15-54)91(138)114-70(35-55-16-6-3-7-17-55)93(140)121-77(43-84(105)133)98(145)117-71(36-56-25-29-62(129)30-26-56)92(139)115-72(37-57-27-31-63(130)32-28-57)94(141)123-79(103(150)151)40-60-47-110-89-66(60)20-12-24-82(89)131/h2-12,14-22,24-32,45-48,52-53,69-81,88,107-108,110,127-131H,13,23,33-44,49-51H2,1H3,(H2,104,132)(H2,105,133)(H,106,112)(H,109,134)(H,111,137)(H,113,135)(H,114,138)(H,115,139)(H,116,142)(H,117,145)(H,118,144)(H,119,146)(H,120,143)(H,121,140)(H,122,147)(H,123,141)(H,124,148)(H,125,136)(H,150,151) |
| InChI Key | JHNVFWSVMMAWSD-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C103H115N23O25 |
| Molecular Weight | 2075.20 g/mol |
| Exact Mass | 2074.84680108 g/mol |
| Topological Polar Surface Area (TPSA) | 757.00 Ų |
| XlogP | 1.20 |
| Atomic LogP (AlogP) | -3.65 |
| H-Bond Acceptor | 25 |
| H-Bond Donor | 27 |
| Rotatable Bonds | 37 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8839 | 88.39% |
| Caco-2 | - | 0.8611 | 86.11% |
| Blood Brain Barrier | - | 0.9000 | 90.00% |
| Human oral bioavailability | - | 0.7286 | 72.86% |
| Subcellular localzation | Mitochondria | 0.5003 | 50.03% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8177 | 81.77% |
| OATP1B3 inhibitior | + | 0.9405 | 94.05% |
| MATE1 inhibitior | - | 0.9209 | 92.09% |
| OCT2 inhibitior | - | 0.7500 | 75.00% |
| BSEP inhibitior | + | 0.9576 | 95.76% |
| P-glycoprotein inhibitior | + | 0.7418 | 74.18% |
| P-glycoprotein substrate | + | 0.8809 | 88.09% |
| CYP3A4 substrate | + | 0.7640 | 76.40% |
| CYP2C9 substrate | - | 0.7935 | 79.35% |
| CYP2D6 substrate | - | 0.8362 | 83.62% |
| CYP3A4 inhibition | - | 0.8323 | 83.23% |
| CYP2C9 inhibition | - | 0.8995 | 89.95% |
| CYP2C19 inhibition | - | 0.8783 | 87.83% |
| CYP2D6 inhibition | - | 0.8836 | 88.36% |
| CYP1A2 inhibition | - | 0.8834 | 88.34% |
| CYP2C8 inhibition | + | 0.8344 | 83.44% |
| CYP inhibitory promiscuity | - | 0.6992 | 69.92% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.6088 | 60.88% |
| Eye corrosion | - | 0.9914 | 99.14% |
| Eye irritation | - | 0.8953 | 89.53% |
| Skin irritation | - | 0.8037 | 80.37% |
| Skin corrosion | - | 0.9447 | 94.47% |
| Ames mutagenesis | - | 0.7500 | 75.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7119 | 71.19% |
| Micronuclear | + | 0.9000 | 90.00% |
| Hepatotoxicity | - | 0.5434 | 54.34% |
| skin sensitisation | - | 0.9043 | 90.43% |
| Respiratory toxicity | + | 0.9000 | 90.00% |
| Reproductive toxicity | + | 0.9778 | 97.78% |
| Mitochondrial toxicity | + | 0.9375 | 93.75% |
| Nephrotoxicity | + | 0.5907 | 59.07% |
| Acute Oral Toxicity (c) | III | 0.5890 | 58.90% |
| Estrogen receptor binding | - | 0.5867 | 58.67% |
| Androgen receptor binding | + | 0.7107 | 71.07% |
| Thyroid receptor binding | + | 0.8250 | 82.50% |
| Glucocorticoid receptor binding | + | 0.8498 | 84.98% |
| Aromatase binding | + | 0.8225 | 82.25% |
| PPAR gamma | + | 0.7672 | 76.72% |
| Honey bee toxicity | - | 0.6397 | 63.97% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.6800 | 68.00% |
| Fish aquatic toxicity | - | 0.4864 | 48.64% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.98% | 98.95% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.97% | 83.82% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.64% | 97.64% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.57% | 96.09% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 99.14% | 90.08% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 98.70% | 88.56% |
| CHEMBL3837 | P07711 | Cathepsin L | 98.48% | 96.61% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 98.08% | 95.56% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 97.34% | 91.11% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 97.30% | 90.20% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 97.09% | 95.89% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 96.96% | 96.31% |
| CHEMBL1951 | P21397 | Monoamine oxidase A | 96.71% | 91.49% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 96.29% | 94.45% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 95.90% | 85.14% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 95.22% | 91.81% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 95.03% | 92.97% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 93.98% | 97.23% |
| CHEMBL2535 | P11166 | Glucose transporter | 93.93% | 98.75% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 93.59% | 99.18% |
| CHEMBL1801 | P00747 | Plasminogen | 92.69% | 92.44% |
| CHEMBL4644 | P41968 | Melanocortin receptor 3 | 92.57% | 99.52% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 92.28% | 99.15% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 91.91% | 95.50% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 91.86% | 90.24% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 91.47% | 88.42% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 90.65% | 99.23% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.59% | 97.09% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 90.05% | 82.38% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 89.93% | 96.11% |
| CHEMBL2093869 | P05106 | Integrin alpha-IIb/beta-3 | 89.81% | 95.42% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 89.62% | 95.38% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 89.48% | 99.17% |
| CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 89.38% | 99.09% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 89.36% | 89.00% |
| CHEMBL6175 | Q9H3R0 | Lysine-specific demethylase 4C | 89.36% | 96.69% |
| CHEMBL213 | P08588 | Beta-1 adrenergic receptor | 89.25% | 95.56% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 89.07% | 88.10% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 88.83% | 98.05% |
| CHEMBL264 | Q9Y5N1 | Histamine H3 receptor | 87.87% | 91.43% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 87.82% | 94.75% |
| CHEMBL2095226 | P05556 | Integrin alpha-5/beta-1 | 86.46% | 96.39% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 86.40% | 96.90% |
| CHEMBL2095172 | P14867 | GABA-A receptor; alpha-1/beta-2/gamma-2 | 85.85% | 92.67% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 85.45% | 96.67% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 85.38% | 92.12% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 85.16% | 90.93% |
| CHEMBL5805 | Q9NR97 | Toll-like receptor 8 | 85.07% | 96.25% |
| CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 84.79% | 91.71% |
| CHEMBL4447 | Q9Y337 | Kallikrein 5 | 84.64% | 87.50% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 84.59% | 95.83% |
| CHEMBL4071 | P08311 | Cathepsin G | 84.12% | 94.64% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 83.88% | 94.00% |
| CHEMBL4101 | P17612 | cAMP-dependent protein kinase alpha-catalytic subunit | 83.84% | 82.86% |
| CHEMBL1795185 | Q58F21 | Bromodomain testis-specific protein | 83.50% | 89.76% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 83.49% | 86.33% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 83.24% | 98.24% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 82.57% | 100.00% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 82.01% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 81.45% | 97.14% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 81.29% | 100.00% |
| CHEMBL3155 | P34969 | Serotonin 7 (5-HT7) receptor | 81.15% | 90.71% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 80.74% | 83.10% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 163061240 |
| LOTUS | LTS0163108 |
| wikiData | Q104169542 |